English | Español

Biospace
Patient Daily | Feb 3, 2026

Puerto Rico aims for revival as Amgen and Lilly invest billions in local facilities
Patient Daily | Feb 2, 2026

Pharma faces mounting pressure over opaque drug pricing as calls grow for transparency
Patient Daily | Feb 2, 2026

FDA launches PreCheck pilot program to aid U.S. drug manufacturing
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
Patient Daily | Feb 2, 2026

Psychedelic drug developers near key approvals amid changing regulatory landscape
Patient Daily | Jan 30, 2026

FDA recommends using minimal residual disease as key endpoint for multiple myeloma drug approvals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
Patient Daily | Jan 29, 2026

Biopharma sector sees increased hiring plans despite recent layoffs

Trending
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

Rare disease drug developers outline strategies at J.P. Morgan Healthcare conference
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Senate gridlock delays decision on rare disease priority review voucher program
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

SpyGlass Pharma and AgomAb Therapeutics file for Nasdaq IPOs
+ Pharmaceuticals
Patient Daily | Jan 27, 2026

FDA extends review timelines for four priority voucher drugs